Abstract: The anti-hepatitis B virus activity and hepatoprotective activity of a liquid fermentation broth of Ganoderma lucidum were investigated. The cultured broth was supplemented with aqueous extract of Radix Sophorae flavescentis, a kind of Chinese herbal medicine. Our results indicated that the cultured broth had effects of anti-hepatitis B virus activity in vitro and protected mice from liver damage in vivo. Our results also indicated that the co-fermentation broth of Ganoderma lucidum in the presence of aqueous extract of Radix Sophorae flavescentis has better medicinal effects than simply mixing these two ingredients together, suggesting a potential novel way to prepare Chinese herbal mixtures.
Introduction
Ganoderma lucidum (Fr.) Krast (Polyporaceae), a member of the basidiomycete family, is a traditional Chinese medicine generally used for invigorating healthy qi and strengthening body resistance to diseases. Recent literatures showed that G. lucidum had the ability to regulate and boost the immune system , suppress tumor growth (Wang et al., 1997) , inhibit viral infection (Sahar et al., 1998; Kim et al., 2000) , and enhance hepatic functions (Back et al., 1999) . The dried root of Sophora flavescens Ait. is another traditional Chinese medicine named Radix Sophorae flavescentis (RSF). It is often used for the treatment of skin and mucosal ulcers and sores, gastrointestinal hemorrhage, diarrhea, inflammation, and arrhythmia. In recent years, the antiviral effects of RSF have attracted considerable attention (Ma et al., 2002) and RSF has been used in prescriptions for the treatment of chronic hepatitis B virus (Liu et al., 2003) .
In traditional Chinese medicine practices, G. lucidum is usually used in conjunction with other traditional Chinese medicines, such as RSF. A common practice of such clinical approach is to allow RSF and the fruiting body of G. lucidum to be decocted together to treat hepatitis. The fruiting body of G. lucidum grows slowly and it takes several months before it can be harvested. In addition, the quality of G. lucidum varies from batch to batch depending on the growth conditions. Therefore, a faster and more quality consistent method is needed to grow G. lucidum. In several recent reports, it was demonstrated that the liquid fermentation broth of G. lucidum can be produced and harvested in less than a week (Yang and Liau, 1998; Fang and Zhong, 2002) . It was further demonstrated that the liquid fermentation broth of G. lucidum culture has the same medical effects as the fruiting body.
In the present study, G. lucidum was cultured in a medium supplemented with an aqueous extract of RSF. It is anticipated that the RSF extract will not only mix with the cultured broth, but also participate in the fermentation process of G. lucidum. We found that the fermentation broth of G. lucidum, when supplemented with the RSF extracts, has higher anti-hepatitis B virus activity than the non-supplemented broth, as well as the RSF extracts alone. Our results suggested that the co-fermentation process may bring out some novel ingredients with desired medicinal effects. Our liquid co-fermentation process provided a novel methodology to the preparation of Chinese herbal mixture for medicinal usage. Bio-products (Shanghai, China) . RSF was purchased from SHANHE Pharmaceutical Group (Wuxi, China). All the other chemicals used were at least reagent grade.
Materials and Methods

Materials and Chemicals
Animals
Male KM mice weighing 18-22 g (seven weeks of age) were housed in a temperature controlled room (23 ± 3°C) with lighting maintained at a 12-hour light/dark cycle. Animals were fed with a standard laboratory chow and water ad libitum. Animals were randomly divided into control, hepatotoxin-treated and medicine-treated groups (ten mice in each group).
Preculture of G. lucidum
The strain of G. lucidum CCGMC 5.616 was purchased from China General Microbiological Fermentation Collection Center (Beijing, China). Preculture medium contained (g l −1 ):
glucose, 40; peptone, 4; yeast extract, 2; KH 2 PO 4 ·3H 2 O, 1.5; MgSO 4 ·7H 2 O, 0.75; vitamin B 1 , 0.01. G. lucidum was grown in a 250 ml flask containing 70 ml medium at 30˚C for 7 days with shaking at 150 rpm.
Preparation of RSF Extracts (RSFE)
After having soaked for 1 hour, 1 kg sliced RSF was extracted with 6 liters of boiling water for 30 minutes. The residue was subjected to further extraction in 4 liters of boiling water. The decoction from the two successive extractions was combined and filtered through a filter paper (Xinhua No.1 filter paper). The filtrate was collected and lyophilized.
Preparation of Cultured Broth of G. lucidum (GL)
A broth of G. lucidum was prepared through cultivation in a basic medium that contained (g l −1 ): glucose, 40; peptone, 4; yeast extract, 2; KH 2 PO 4 ·3H 2 O, 1.5; MgSO 4 ·7H 2 O, 0.75;
and vitamin B 1 , 0.01. 70 ml medium was added into a 250 ml flask and inoculated with 8 ml precultured broth. After 96 hours of cultivation at 30ºC on a rotary shaker (150 rpm), the mycelia were removed from the cultured broth by centrifugation, and the supernatant was concentrated and lyophilized.
Broth of G. lucidum Cultured with the Extracts from RSF (BGR)
BGR was prepared by culturing G. lucidum in the medium described above except with the addition of 10 g/l lyophilized RSF extract. The culture conditions and supernatant harvest were performed as described above.
Mixture of RSF Extract and Broth of G. lucidum (Mix.)
A mixture was prepared with 10 g dried RSF extract and 1 liter G. lucidum broth which was cultured in the basic medium as GL and the mycelia removed by centrifugation. After thorough mixing, the mixture was concentrated at 50ºC and finally lyophilized.
Cell Culture
Hepatitis B virus (HBV) transfected human hepatoma HepG2-2.2.15 cells (Sells et al., 1987) were maintained in MEM with 10% fetal bovine serum, 100 units/ml of streptomycin and penicillin, 1 mM glutamine and 200 µg/ml G418. Cells were seeded into 24-well plates at the density of 10 5 cells/well. After 3 days of incubation, the medium was replaced with fresh medium containing test samples at various concentrations (the control group contained no test samples). Fetal bovine serum and G418 in the fresh medium were changed to 2% and 380 µg/ml, respectively. After 4 days of incubation, the cultured medium was replaced again with fresh medium containing the same test samples. To measure the effects of test samples on cell growth, culture medium at day 12 was replaced with PBS solution containing 0.5 mg/ml MTT. After 4 hours of incubation, PBS solution was removed and 1 ml dimethyl sulfoxide was added into each well. Absorbance (A) at 490 nm was measured and the cytotoxicity was calculated with the formula as rate of living cell (RLC) 
CCl 4 -Induced Hepatotoxicity in Mice
Mice were randomly divided into 11 groups of ten animals each. Normal control group received 10 ml/kg olive oil (i.p.) and 30 ml/kg·day saline (i.g.). The model group was given olive oil with CCl 4 (0.1%, 10 ml/kg, i.p.). The standard reference group received CCl 4 /olive oil (0.1%, 10 ml/kg, i.p.) and DDB (200 mg/kg in saline, i.g.). The test groups were treated with CCl 4 /olive oil (0.1%, 10 ml/kg, i.p.) and BGR, Mix, RSFE or GL (100 mg or 300 mg/kg i.g.), respectively, prepared as mentioned above in saline solution.
Animals were treated for 7 consecutive days before CCl 4 /olive oil administration. No food was provided after CCl 4 administration, but tap water was made available ad libitum. Blood was drawn from the eye socket 16 hours after CCl 4 administration. Blood samples were centrifuged at 3000 g and 4°C for 10 minutes to obtain the serum. The activities of alanine aminotransferase (ALT) and aspartate aminotransferase (AST) in the serum were measured with VENUSLEON-180 Eos bravo biochemistry measuring system (Hospitex Diagnostics Landao Laboratories LTD, Italy).
BCG/LPS-Induced Hepatotoxicity in Mice
Mice were randomly divided into 12 groups of ten animals each. Normal control group was given 30 ml/kg·day saline (i.g.). In the other 11 groups, each animal was treated with 0.2 ml BCG (contained 5 × 10 6 bacteria, i.v) on the first day. Then, the model group received 30 ml/kg·day saline (i.g.). The two standard reference groups were given either 200 mg/kg·day DDB (i.g.) or 20 mg/kg·day CP (i.g.). The treated groups were given a prepared drug samples (BGR, Mix, RSFE or GL), which was suspended in saline at a dose of 100 mg or 300 mg/kg (i.g.), respectively. Ten days later, each animal except normal control was given 7.5 µg LPS (i.v.). 16 hours later, blood was drawn from the eye socket. The blood samples treatment and the activities of ALT and AST measurements as mentioned above.
Statistical Analysis
All values were presented as mean ± SD. Completely randomized design and t-test were used to analyze the statistical difference between the treatment and the control groups. A level of difference of p < 0.05 was considered significant.
Results
The results in Table 1 indicated that the fermentation broth of G. lucidum in the presence of RSF extract (BGR) inhibited 2.2.15 cells to secret HBsAg and HBeAg. The extent of inhibition seems to be dose effective. In addition, the inhibitory effects of BGR seem to be higher than all the other test samples (Mix, RSFE and GL). The cytotoxicity of both Mix and RSFE was higher than BGR. However, GL had low cytotoxicity on the 2.2.15 cells at the tested dosages.
CCl 4 induced a marked increase of ALT and AST levels in mice serum as shown in Table 2 . However, administration with BGR significantly (p < 0.01) decreased the ALT and AST levels and the effects appeared to be dose-dependent. Our results also indicated that BGR, Mix and RSFE, but not GL, had significant protective effects on hepatotoxicity induced by CCl 4 .
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Discussion and Conclusions
Hepatitis B is a disease caused by the hepatitis B virus. Liver cell injury is its primary characteristic. Therefore, it is very important that an anti-hepatitis B medicine has effects of both anti-virus activity and hepatoprotection. HepG2 2.2.15 cell line originated from an independent transfection of HepG2 cells with HBV DNA (Sells et al., 1987) and it was established as an in vitro model system for analyses of HBV replication (Sells et al., 1987; Sureau et al., 1986) . The results presented in this paper clearly demonstrated the anti-HBV activities of a liquid fermentation broth of G. lucidum supplemented with RSF extract. The co-fermentation broth of G. lucidum with RSF extracts has better antiviral and hepatoprotective activities than simply mixing the cultured broth of G. lucidum with RSF extracts (Mix).
CCl 4 -induced hepatotoxicity and BCG + LPS-induced liver injury models are conventionally used for the investigation of novel liver protective agents. Administration of CCl 4 and BCG + LPS caused a rapid increase in ALT and AST levels. Serum transaminase elevation has been reported to be associated with a number of inflammatory disorders (Hoder and Wilkinson, 1980) and hepatocellular damage (Sinha and Saran, 1972) . Leakage of large quantities of enzymes into the blood stream is often associated with massive necrosis of the liver (Rees and Spector, 1961) . CCl 4 -induced acute liver injury is similar to the damage of acute hepatitis (Recknagel, 1967) .
In this study, the anti-HBV effects of BGR in vitro were more significant than the other three samples and the cytotoxicity of BGR was lower than Mix and RSFE. It suggested that fermentation of RSF extracts with G. lucidum might have promoted its anti-HBV effects and reduced its cytotoxicity.
The protective effects of BGR on chemical liver injury showed no significant difference compared to Mix and RSFE, but were better than GL in this research. The fact that BGR and Mix all contained RSFE suggested that the protective effects on chemical liver injury induced by CCl 4 might mainly be contributed by RSFE and that the fermentation with G. lucidum did not reduce the protective effects of RSFE. However, the protective effect of BGR on autoimmune liver injury was significantly better than the other three samples. These results suggest that the co-fermentation of G. lucidum with RSFE has additive effects on the protection of autoimmune liver injury induced by BCG + LPS.
In conclusion, our study demonstrated that the liquid fermentation of G. lucidum is an effective way to process medicinal herbs. Addition of the RSF extract during the fermentation process augmented the anti-HBV virus activity in vitro, as well as the hepatoprotective effects in vivo.
